No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr17:46547400-46551600 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
2 |
chr17:46547600-46550800 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
3 |
chr17:46547800-46550800 |
Enhancers |
NHDF-Ad |
bronchial
|
4 |
chr17:46547800-46551000 |
Enhancers |
HMEC |
breast
|
5 |
chr17:46548200-46550800 |
Enhancers |
H1 Cell Line |
embryonic stem cell
|
6 |
chr17:46548200-46551000 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
7 |
chr17:46548400-46550800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
8 |
chr17:46548600-46550800 |
Enhancers |
HUES6 Cell Line |
embryonic stem cell
|
9 |
chr17:46548600-46550800 |
Enhancers |
NHEK |
skin
|
10 |
chr17:46548800-46550800 |
Enhancers |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
11 |
chr17:46548800-46550800 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
12 |
chr17:46549200-46550800 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
13 |
chr17:46549200-46550800 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
14 |
chr17:46549200-46550800 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
15 |
chr17:46549400-46550800 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
16 |
chr17:46549400-46550800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
17 |
chr17:46549400-46550800 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
18 |
chr17:46549400-46550800 |
Enhancers |
NH-A |
brain
|
19 |
chr17:46549400-46551000 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
20 |
chr17:46549400-46551000 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
21 |
chr17:46549600-46550800 |
Enhancers |
A549 |
lung
|
22 |
chr17:46549600-46550800 |
Enhancers |
Osteobl |
bone
|
23 |
chr17:46549800-46550800 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
24 |
chr17:46549800-46550800 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
25 |
chr17:46549800-46550800 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
26 |
chr17:46550000-46550800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
27 |
chr17:46550200-46551400 |
Enhancers |
HSMM |
muscle
|
28 |
chr17:46550400-46554200 |
Weak transcription |
Primary hematopoietic stem cells short term culture |
blood
|
29 |
chr17:46550400-46554800 |
Weak transcription |
GM12878-XiMat |
blood
|
30 |
chr17:46550400-46555200 |
Weak transcription |
Primary hematopoietic stem cells |
blood
|
31 |
chr17:46550600-46550800 |
Bivalent Enhancer |
iPS-20b Cell Line |
embryonic stem cell
|
32 |
chr17:46550600-46550800 |
Enhancers |
Fetal Kidney |
kidney
|
33 |
chr17:46550600-46553600 |
Weak transcription |
K562 |
blood
|
34 |
chr17:46550600-46554600 |
Weak transcription |
Primary T cells fromperipheralblood |
blood
|
35 |
chr17:46550600-46554800 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
36 |
chr17:46550600-46555800 |
Weak transcription |
Primary T killer naive cells fromperipheralblood |
blood
|